Guided Therapeutics (GTHP) Equity Ratio (2010 - 2025)
Guided Therapeutics recorded quarterly Equity Ratio of 4.53 in Q4 2025, up 28.21% quarter-over-quarter from 6.31 in Q3 2025, and down 27.73% year-over-year from 6.27 in Q4 2024.
Guided Therapeutics' Equity Ratio history runs 16 years deep, the most recent figure standing at 4.53 for Q4 2025.
- In Q4 2025, Equity Ratio fell 27.73% year-over-year to 4.53; the TTM figure through Dec 2025 stood at 4.53 (down 27.73% YoY), while the FY2025 annual figure was 4.53, down 27.73% from the prior year.
- Equity Ratio came in at 4.53 for Q4 2025 at Guided Therapeutics, up from 6.31 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.68 in Q3 2022 to a low of 6.31 in Q3 2025.
- A 5-year average of 3.22 and a median of 3.47 in 2021 frame the typical range for Equity Ratio.
- Across the five-year window, Equity Ratio jumped 89.14% in 2021 and tumbled 183.95% in 2023, its largest moves.
- Guided Therapeutics' Equity Ratio stood at 2.67 in 2021, then jumped by 67.91% to 0.86 in 2022, then sank by 166.25% to 2.28 in 2023, then tumbled by 55.58% to 3.55 in 2024, then declined by 27.73% to 4.53 in 2025.
- According to Business Quant data, Equity Ratio over the past three periods registered 4.53, 6.31, and 5.82 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -4.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.53 |
| Sep 30, 2025 | -6.31 |
| Jun 30, 2025 | -5.82 |
| Mar 31, 2025 | -5.20 |
| Dec 31, 2024 | -3.55 |
| Sep 30, 2024 | -3.94 |
| Jun 30, 2024 | -3.73 |
| Mar 31, 2024 | -2.69 |
| Dec 31, 2023 | -2.28 |
| Sep 30, 2023 | -1.94 |
| Jun 30, 2023 | -1.41 |
| Mar 31, 2023 | -0.99 |
| Dec 31, 2022 | -0.86 |
| Sep 30, 2022 | -0.68 |
| Jun 30, 2022 | -3.84 |
| Mar 31, 2022 | -2.28 |
| Dec 31, 2021 | -2.67 |
| Sep 30, 2021 | -4.44 |
| Jun 30, 2021 | -3.87 |
| Mar 31, 2021 | -3.38 |
| Dec 31, 2020 | -8.04 |
| Sep 30, 2020 | -10.63 |
| Jun 30, 2020 | -17.43 |
| Mar 31, 2020 | -31.17 |
| Dec 31, 2019 | -14.35 |
| Sep 30, 2019 | -53.15 |
| Jun 30, 2019 | -71.48 |
| Mar 31, 2019 | -39.63 |
| Dec 31, 2018 | -67.05 |
| Sep 30, 2018 | -28.86 |
| Jun 30, 2018 | -34.01 |
| Mar 31, 2018 | -34.04 |
| Dec 31, 2017 | -47.79 |
| Sep 30, 2017 | -13.64 |
| Jun 30, 2017 | -6.86 |
| Mar 31, 2017 | -6.07 |
| Dec 31, 2016 | -6.21 |
| Sep 30, 2016 | -3.55 |
| Jun 30, 2016 | -3.09 |
| Mar 31, 2016 | -2.30 |
| Dec 31, 2015 | -2.21 |
| Sep 30, 2015 | -1.26 |
| Jun 30, 2015 | -0.68 |
| Mar 31, 2015 | -1.96 |
| Dec 31, 2014 | -1.47 |
| Sep 30, 2014 | -1.06 |
| Jun 30, 2014 | -0.65 |
| Mar 31, 2014 | -0.49 |
| Dec 31, 2013 | -0.03 |
| Sep 30, 2013 | 0.18 |
| Jun 30, 2013 | 0.40 |
| Mar 31, 2013 | 0.52 |
| Dec 31, 2012 | 0.33 |
| Sep 30, 2012 | 0.45 |
| Jun 30, 2012 | 0.12 |
| Mar 31, 2012 | 0.29 |
| Dec 31, 2011 | 0.37 |
| Jun 30, 2011 | 0.12 |
| Dec 31, 2010 | 0.26 |